Abstract
Diabetes mellitus (DM) and complications associated with diabetes are one of the leading causes of death worldwide. The International Diabetes Federation (IDF) has estimated that 592 million people will suffer from diabetes by 2035. Therefore, it is vital to find a new biomolecule that can further help in the treatment of diabetes. For several decades, a persistent interest in the biological properties of melatonin (MT) has been maintained in biological science and medicine. In recent years, a lot of information has appeared about its participation in maintaining energy homeostasis and the genesis of diabetes mellitus. The purpose of this review is to study the pathogenetic mechanism of melatonin in diabetes mellitus
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The American Journal of Medical Sciences and Pharmaceutical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
